{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:09:57Z","timestamp":1762506597118},"reference-count":28,"publisher":"Saudi Heart Association","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journalofthesaudiheart.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Saudi Heart Association"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jsha.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T05:44:09Z","timestamp":1437198249000},"page":"81-88","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["N-terminal-pro-brain natriuretic peptide, a surrogate biomarker of combined clinical and hemodynamic outcomes following percutaneous transvenous mitral commissurotomy"],"prefix":"10.37616","volume":"28","author":[{"given":"K.P.","family":"Ranganayakulu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rajasekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Vanajakshamma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Santosh Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vasudeva Chetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24531","reference":[{"key":"10.1016\/j.jsha.2015.07.002_b0005","first-page":"643","article-title":"Rheumatic fever and rheumatic heart disease: the last 50years","volume":"137","author":"Krishna Kumar","year":"2013","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jsha.2015.07.002_b0010","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ehj.2003.07.005","article-title":"N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure","volume":"24","author":"Gardner","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jsha.2015.07.002_b0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijcard.2006.10.009","article-title":"Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure","volume":"120","author":"Bayes-Genis","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jsha.2015.07.002_b0020","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(00)02060-2","article-title":"Treatment of heart failure guided by amino-terminal brain natriuretic peptide (N-BNP) concentrations","volume":"355","author":"Troughton","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jsha.2015.07.002_b0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0954-6111(99)90094-X","article-title":"Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with corpulmonale","volume":"93","author":"Bando","year":"1999","journal-title":"Respir Med"},{"key":"10.1016\/j.jsha.2015.07.002_b0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(97)00452-X","article-title":"Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension","volume":"31","author":"Nagaya","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jsha.2015.07.002_b0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.hlc.2011.03.112","article-title":"Comparison of atrial and brain natriuretic peptide for the assessment of mitral stenosis","volume":"20","author":"Sharma","year":"2011","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jsha.2015.07.002_b0040","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jacc.2009.06.013","article-title":"Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation","volume":"54","author":"Pizarro","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jsha.2015.07.002_b0045","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cjca.2014.07.014","article-title":"The role of biomarkers in valvular heart disease: focus on natriuretic peptides","volume":"30","author":"Bergler-Klein","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jsha.2015.07.002_b0050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs0870671","article-title":"Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy","volume":"87","author":"Tharaux","year":"1994","journal-title":"Clin Sci"},{"key":"10.1016\/j.jsha.2015.07.002_b0055","first-page":"185","article-title":"Neurohormones in MS before and after percutaneous balloon mitral valvotomy","volume":"11","author":"Razzolini","year":"2002","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.jsha.2015.07.002_b0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ejheart.2004.04.018","article-title":"Plasma B-type natriuretic peptide in patients with rheumatic heart disease","volume":"6","author":"Golbasy","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jsha.2015.07.002_b0065","first-page":"735","article-title":"NT pro B-type natriuretic peptide levels correlate with severity of mitral stenosis","volume":"74","author":"Iltumur","year":"2005","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.jsha.2015.07.002_b0070","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1540-8175.2005.04085.x","article-title":"Serum NT pro B-type natriuretic peptide levels correlate with symptoms and echocardiographic findings in patients with mitral stenosis","volume":"22","author":"Arat-Ozkan","year":"2005","journal-title":"Echocardiography"},{"key":"10.1016\/j.jsha.2015.07.002_b0075","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ejheart.2004.07.006","article-title":"Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease","volume":"7","author":"Davutoglu","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jsha.2015.07.002_b0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10554-006-9174-8","article-title":"The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis","volume":"23","author":"Eryol","year":"2007","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jsha.2015.07.002_b0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/AC.67.1.2146566","article-title":"Valvular heart disease: plasma B-type natriuretic peptide levels in patients with pure rheumatic mitral stenosis","volume":"67","author":"Ucar","year":"2012","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jsha.2015.07.002_b0090","first-page":"453","article-title":"Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation","volume":"14","author":"Shang","year":"2005","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.jsha.2015.07.002_b0095","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1536\/ihj.48.579","article-title":"The effect of percutaneous balloon mitral valvuloplasty on N-terminal-proB-type natriuretic peptide plasma levels in mitral stenosis","volume":"48","author":"Seluck","year":"2007","journal-title":"Int Heart J"},{"key":"10.1016\/j.jsha.2015.07.002_b0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijcard.2009.01.001","article-title":"N-terminal pro-BNP plasma levels before and after percutaneous transvenous mitral commissurotomy for mitral stenosis","volume":"144","author":"Chadha","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jsha.2015.07.002_b0105","first-page":"e2","article-title":"Correlation between levels of NT-proBNP and cardiac function after percutaneous balloon mitral valvotomy in mitral stenosis","volume":"8","author":"Nitin","year":"2010","journal-title":"Calicut Med J"},{"key":"10.1016\/j.jsha.2015.07.002_b0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15171\/jcvtr.2014.007","article-title":"Changes in serum NT-Pro BNP and left atrial BNP levels after percutaneous transvenous mitral commissurotomy in sinus rhythm versus atrial fibrillation","volume":"6","author":"Pourafkari","year":"2014","journal-title":"J Cardiovasc Thorac Res"},{"key":"10.1016\/j.jsha.2015.07.002_b0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/joic.12050","article-title":"The impact of right ventricular stroke work on B-type natriuretic peptide levels in patients with mitral stenosis undergoing percutaneous mitral valvuloplasty","volume":"26","author":"Esteves","year":"2013","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jsha.2015.07.002_b0120","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jsha.2015.07.002_b0125","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jsha.2015.07.002_b0130","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1093\/eurheartj\/12.suppl_B.99","article-title":"Percutaneous transvenous mitral commissurotomy using the Inoue balloon","volume":"12","author":"Inoue","year":"1991","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jsha.2015.07.002_b0135","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijcard.2007.04.059","article-title":"ANP and BNP in atrial fibrillation before and after cardioversion and their relationship to cardiac volume and function","volume":"127","author":"Therkelsen","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jsha.2015.07.002_b0140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/eurheartj\/ehm577","article-title":"Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions","volume":"29","author":"Sacher","year":"2008","journal-title":"Eur Heart"}],"container-title":["Journal of the Saudi Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016731515001591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016731515001591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016731515001591?httpAccept=text\/plain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T17:44:52Z","timestamp":1666115092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1016731515001591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1016731515001591"],"URL":"https:\/\/doi.org\/10.1016\/j.jsha.2015.07.002","relation":{},"ISSN":["1016-7315"],"issn-type":[{"value":"1016-7315","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-terminal-pro-brain natriuretic peptide, a surrogate biomarker of combined clinical and hemodynamic outcomes following percutaneous transvenous mitral commissurotomy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Saudi Heart Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsha.2015.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}